메뉴 건너뛰기




Volumn 17, Issue 2, 1999, Pages 100-106

In vitro effect of Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) analogs resistant to angiotensin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation

Author keywords

ACE; AcSDKP; AcSDKP analogs; Hematopoietic stem cell; Proliferation inhibitor; Pseudopeptides

Indexed keywords

ACETYL N SERYLASPARTYLLYSYLPROLINE; ACETYLSERINE PSI (METHYLAMINE)ASPARTYLLYSYLPROLINE; ACETYLSERYLASPARTYL PSI (METHYLAMINE)LYSYLPROLINE; ACETYLSERYLASPARTYLLYSYL PSI (METHYLENE AMINO)PROLINE; ACETYLSERYLASPARTYLLYSYLPROLINE AMIDE; DIPEPTIDYL CARBOXYPEPTIDASE; PSEUDOPEPTIDE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

EID: 0033014513     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.170100     Document Type: Article
Times cited : (23)

References (41)
  • 1
    • 0025836321 scopus 로고
    • Clinical implications of positive and negative hematopoietic stem cell regulators
    • Moore MAS. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991;78:1-19.
    • (1991) Blood , vol.78 , pp. 1-19
    • Moore, M.A.S.1
  • 3
    • 0028338616 scopus 로고
    • Hematopoietic growth factors in cancer treatment
    • Büchner T. Hematopoietic growth factors in cancer treatment. STEM CELLS 1994;12:241-252.
    • (1994) STEM CELLS , vol.12 , pp. 241-252
    • Büchner, T.1
  • 4
    • 0027371503 scopus 로고
    • Ways of minimizing hematopoietic damage induced by radiation and cytostatic drugs - The possible role of inhibitors
    • Tubiana M, Carde P, Frindel E. Ways of minimizing hematopoietic damage induced by radiation and cytostatic drugs - the possible role of inhibitors. Radiother Oncol 1993;29:1-17.
    • (1993) Radiother Oncol , vol.29 , pp. 1-17
    • Tubiana, M.1    Carde, P.2    Frindel, E.3
  • 5
    • 0029565872 scopus 로고
    • Inhibitors of haemopoiesis and their potential clinical relevance
    • Parker AN, Pragnell IB. Inhibitors of haemopoiesis and their potential clinical relevance. Blood Rev 1995;9:226-233.
    • (1995) Blood Rev , vol.9 , pp. 226-233
    • Parker, A.N.1    Pragnell, I.B.2
  • 6
    • 0001645294 scopus 로고
    • Inhibitor of hematopoietic pluripotent stem cell proliferation: Purification and determination of its structure
    • Lenfant M, Wdzieczak-Bakala J, Guittet E et al. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci USA 1989;86:779-782.
    • (1989) Proc Natl Acad Sci USA , vol.86 , pp. 779-782
    • Lenfant, M.1    Wdzieczak-Bakala, J.2    Guittet, E.3
  • 8
    • 0026447759 scopus 로고
    • The mechanism of action of the tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation
    • Robinson S, Lenfant M, Wdzieczak-Bakala J et al. The mechanism of action of the tetrapeptide Acelyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation. Cell Prolif 1992;25:623-632.
    • (1992) Cell Prolif , vol.25 , pp. 623-632
    • Robinson, S.1    Lenfant, M.2    Wdzieczak-Bakala, J.3
  • 9
    • 0025202850 scopus 로고
    • Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP
    • Guigon M, Bonnet D, Lemoine F et al. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp Hematol 1990;18:1112-1115.
    • (1990) Exp Hematol , vol.18 , pp. 1112-1115
    • Guigon, M.1    Bonnet, D.2    Lemoine, F.3
  • 10
    • 0029933423 scopus 로고    scopus 로고
    • Activity of Acetyl-Ser-Asp-Lys-Pro (AcSDKP) on hematopoietic progenitors in short-term and long-term murine bone marrow cultures
    • Jackson JD, Yan Y, Ewel C et al. Activity of Acetyl-Ser-Asp-Lys-Pro (AcSDKP) on hematopoietic progenitors in short-term and long-term murine bone marrow cultures. Exp Hematol 1996;24:475-481.
    • (1996) Exp Hematol , vol.24 , pp. 475-481
    • Jackson, J.D.1    Yan, Y.2    Ewel, C.3
  • 11
    • 0026500752 scopus 로고
    • The tetrapeptide AcSDKP, an inhibitor of cell cycle status for normal human hematopoietic progenitors has no effect on leukemic cells
    • Bonnet D, Cesaire R, Lemoine F et al. The tetrapeptide AcSDKP, an inhibitor of cell cycle status for normal human hematopoietic progenitors has no effect on leukemic cells. Exp Hematol 1992;20:251-255.
    • (1992) Exp Hematol , vol.20 , pp. 251-255
    • Bonnet, D.1    Cesaire, R.2    Lemoine, F.3
  • 12
    • 0028022981 scopus 로고
    • The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: Evidence for an indirect mechanism
    • Cashman JD, Eaves AC, Eaves CJ. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism. Blood 1994;84:1534-1542.
    • (1994) Blood , vol.84 , pp. 1534-1542
    • Cashman, J.D.1    Eaves, A.C.2    Eaves, C.J.3
  • 13
    • 0027731190 scopus 로고
    • Influence of the peptide AcSerAspLysPro, an hematopoietic inhibitor, on 3′-azido-3′-deoxythymidine-induced in vitro toxicity on human hematopoietic progenitors
    • Grillon C, Bonnet D, Mary JY et al. Influence of the peptide AcSerAspLysPro, an hematopoietic inhibitor, on 3′-azido-3′-deoxythymidine-induced in vitro toxicity on human hematopoietic progenitors. STEM CELLS 1993;11:455-464.
    • (1993) STEM CELLS , vol.11 , pp. 455-464
    • Grillon, C.1    Bonnet, D.2    Mary, J.Y.3
  • 14
    • 0030035025 scopus 로고    scopus 로고
    • The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654)
    • Genevay MC, Mormont C, Thomas F et al. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654). Exp Hematol 1996;24:77-81.
    • (1996) Exp Hematol , vol.24 , pp. 77-81
    • Genevay, M.C.1    Mormont, C.2    Thomas, F.3
  • 15
    • 0028028104 scopus 로고
    • Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP
    • Coutton C, Guigon M, Bohbot A et al. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP. Exp Hematol 1994;22:1076-1080.
    • (1994) Exp Hematol , vol.22 , pp. 1076-1080
    • Coutton, C.1    Guigon, M.2    Bohbot, A.3
  • 16
    • 0029976447 scopus 로고    scopus 로고
    • Goralatide (AcSDKP) selectively protects mutine hematopoietic progenitors and stem cells against hyperthermic damage
    • Wierenga P, Konings AWT. Goralatide (AcSDKP) selectively protects mutine hematopoietic progenitors and stem cells against hyperthermic damage. Exp Hematol 1996;24:246-252.
    • (1996) Exp Hematol , vol.24 , pp. 246-252
    • Wierenga, P.1    Konings, A.W.T.2
  • 17
    • 0030701945 scopus 로고    scopus 로고
    • Reduction of heat induced haematoxicity in a hyperthermic purging protocol of murine acute myeloid leukemic cells by AcSDKP (Goralatide)
    • Wierenga PK, Dillingh JH, Konings AWT. Reduction of heat induced haematoxicity in a hyperthermic purging protocol of murine acute myeloid leukemic cells by AcSDKP (Goralatide). Br J Haematol 1997;99:692-698,
    • (1997) Br J Haematol , vol.99 , pp. 692-698
    • Wierenga, P.K.1    Dillingh, J.H.2    Konings, A.W.T.3
  • 18
    • 0031982923 scopus 로고    scopus 로고
    • Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression
    • Wierenga PK, Brenner MK, Konings AWT. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression. Bone Marrow Transplant 1998;21:73-78.
    • (1998) Bone Marrow Transplant , vol.21 , pp. 73-78
    • Wierenga, P.K.1    Brenner, M.K.2    Konings, A.W.T.3
  • 19
    • 0025873352 scopus 로고
    • Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation
    • Bogden AE, Carde P, Deschamps de Paillette E et al. Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. Ann NY Acad Sci 1991;628:126-139.
    • (1991) Ann NY Acad Sci , vol.628 , pp. 126-139
    • Bogden, A.E.1    Carde, P.2    Deschamps De Paillette, E.3
  • 20
    • 0029841318 scopus 로고    scopus 로고
    • In vivo effect of Platelet Factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil
    • Aidoudi S, Guigon M, Lebburier I et al. In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil. Br J Haematol 1996;94:443-448.
    • (1996) Br J Haematol , vol.94 , pp. 443-448
    • Aidoudi, S.1    Guigon, M.2    Lebburier, I.3
  • 21
    • 0029975460 scopus 로고    scopus 로고
    • In vivo protective effects of tetrapeptide AcSDKP with or without gramilocyte colony-stimulating factor on murine progenitor cells following sublethal irradiation
    • Watanabe T, Brown GS, Kelsey LS et al. In vivo protective effects of tetrapeptide AcSDKP with or without gramilocyte colony-stimulating factor on murine progenitor cells following sublethal irradiation. Exp Hematol 1996;24:713-721.
    • (1996) Exp Hematol , vol.24 , pp. 713-721
    • Watanabe, T.1    Brown, G.S.2    Kelsey, L.S.3
  • 22
    • 0030890442 scopus 로고    scopus 로고
    • In vivo radioprotective effect of AcSDKP on canine myelopoiesis
    • Deeg HJ, Seidel K, Hong DS et al. In vivo radioprotective effect of AcSDKP on canine myelopoiesis. Ann Hematol 1997;74:117-122.
    • (1997) Ann Hematol , vol.74 , pp. 117-122
    • Deeg, H.J.1    Seidel, K.2    Hong, D.S.3
  • 23
    • 0344732253 scopus 로고
    • In vivo effects of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (Seraspenide) on hematopoiesis of normal primates and mice
    • Guigon M, Lemoine F, Dainiak N et al., eds. Paris: Colloque INSERM/John Libbey Eurotext Ltd.
    • Herodin F, Grognier JM, Mestries JC et al. In vivo effects of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (Seraspenide) on hematopoiesis of normal primates and mice. In: Guigon M, Lemoine F, Dainiak N et al., eds. The Negative Regulation of Hematopoiesis, from Fundamenlal Aspects to Clinical Applications. Paris: Colloque INSERM/John Libbey Eurotext Ltd., 1993:189.
    • (1993) The Negative Regulation of Hematopoiesis, from Fundamenlal Aspects to Clinical Applications , pp. 189
    • Herodin, F.1    Grognier, J.M.2    Mestries, J.C.3
  • 24
    • 0031970707 scopus 로고    scopus 로고
    • Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF
    • Bogden AE, Moreau JP, Gamba-Vitalo C et al. Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF. Int J Cancer 1998;76:38-46.
    • (1998) Int J Cancer , vol.76 , pp. 38-46
    • Bogden, A.E.1    Moreau, J.P.2    Gamba-Vitalo, C.3
  • 25
    • 0031962948 scopus 로고    scopus 로고
    • The tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects mice from doxorubicin-induced toxicity: An improvement in both survival and hematological protection for early marrow stem cells and progenitors
    • Masse A, Ramirez LH, Bindoula G et al. The tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects mice from doxorubicin-induced toxicity: an improvement in both survival and hematological protection for early marrow stem cells and progenitors. Blood 1998;91:441-449.
    • (1998) Blood , vol.91 , pp. 441-449
    • Masse, A.1    Ramirez, L.H.2    Bindoula, G.3
  • 26
    • 0027035935 scopus 로고
    • Séraspénide (AcSDKP): Etude en phase I-II d'un inhibiteur de l'hématopoïèse la protégeant de la toxicité de monochimiothérapies aracytine et ifosfamide
    • Carde P, Chastang C, Concalves E et al. Séraspénide (AcSDKP): Etude en phase I-II d'un inhibiteur de l'hématopoïèse la protégeant de la toxicité de monochimiothérapies aracytine et ifosfamide. C R Acad Sci Paris série III 1992;315:545-550.
    • (1992) C R Acad Sci Paris Série III , vol.315 , pp. 545-550
    • Carde, P.1    Chastang, C.2    Concalves, E.3
  • 27
    • 0027432429 scopus 로고
    • Involvement of human plasma angiotensin converting enzyme in the degradation of the hemoregulatory peptide NAc-Ser-Asp-Lys-Pro
    • Rieger K, Saez-Servent N, Papet MP et al. Involvement of human plasma angiotensin converting enzyme in the degradation of the hemoregulatory peptide NAc-Ser-Asp-Lys-Pro. Biochem J 1993;296:373-378.
    • (1993) Biochem J , vol.296 , pp. 373-378
    • Rieger, K.1    Saez-Servent, N.2    Papet, M.P.3
  • 28
    • 0014957830 scopus 로고
    • A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin
    • Yang HYT, Erdos EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970;214:374-376.
    • (1970) Biochim Biophys Acta , vol.214 , pp. 374-376
    • Yang, H.Y.T.1    Erdos, E.G.2    Levin, Y.3
  • 29
    • 0000110931 scopus 로고
    • Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning
    • Soubrier F, Alhenc-Gelas F, Hubert C et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988;85:9386-9390.
    • (1988) Proc Natl Acad Sci USA , vol.85 , pp. 9386-9390
    • Soubrier, F.1    Alhenc-Gelas, F.2    Hubert, C.3
  • 30
    • 0028967315 scopus 로고
    • The hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal site of human angiotensin-converting enzyme
    • Rousseau A, Michaud A, Chauvet MT et al. The hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal site of human angiotensin-converting enzyme. J Biol Chem 1995;270:3656-3661.
    • (1995) J Biol Chem , vol.270 , pp. 3656-3661
    • Rousseau, A.1    Michaud, A.2    Chauvet, M.T.3
  • 31
    • 0030434802 scopus 로고    scopus 로고
    • Single-domain angiotensin I converting enzyme (Kininase II): Characterization and properties
    • Deddish PA, Wang LX, Jackman HL et al. Single-domain angiotensin I converting enzyme (Kininase II): characterization and properties. J Pharmacol Exp Ther 1996;279:1582-1589.
    • (1996) J Pharmacol Exp Ther , vol.279 , pp. 1582-1589
    • Deddish, P.A.1    Wang, L.X.2    Jackman, H.L.3
  • 32
    • 0030027331 scopus 로고    scopus 로고
    • Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline
    • Azizi M, Rousseau A, Ezan E et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J Clin Invest 1996;97:839-844.
    • (1996) J Clin Invest , vol.97 , pp. 839-844
    • Azizi, M.1    Rousseau, A.2    Ezan, E.3
  • 33
    • 0028172132 scopus 로고
    • Pharmacokinetics in healthy volunteers and patients of NacSDKP (Seraspenide), a negative regulator of hematopoiesis
    • Ezan E, Carde P, Le Kerneau J et al. Pharmacokinetics in healthy volunteers and patients of NacSDKP (Seraspenide), a negative regulator of hematopoiesis. Drug Metab Disp 1994;22:843-848.
    • (1994) Drug Metab Disp , vol.22 , pp. 843-848
    • Ezan, E.1    Carde, P.2    Le Kerneau, J.3
  • 34
    • 0030773559 scopus 로고    scopus 로고
    • NAcSDKP analogues resistant to angiotensin-converting enzyme
    • Gaudron S, Adeline MT, Potier P et al. NAcSDKP analogues resistant to angiotensin-converting enzyme. J Med Chem 1997;40:3963-3968.
    • (1997) J Med Chem , vol.40 , pp. 3963-3968
    • Gaudron, S.1    Adeline, M.T.2    Potier, P.3
  • 35
    • 0025350502 scopus 로고
    • Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation
    • Thierry J, Papet MP, Saez-Servent N et al. Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation. J Med Chem 1990;33:2122-2127.
    • (1990) J Med Chem , vol.33 , pp. 2122-2127
    • Thierry, J.1    Papet, M.P.2    Saez-Servent, N.3
  • 36
    • 0024852475 scopus 로고
    • Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. I. The precise point of the cell cycle sensitive to AcSDKP. Studies on the effect of AcSDKP on GM-CFC and on the possible involvement of T lymphocytes in AcSDKP response
    • Monpezat JP, Frindel E. Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. I. The precise point of the cell cycle sensitive to AcSDKP. Studies on the effect of AcSDKP on GM-CFC and on the possible involvement of T lymphocytes in AcSDKP response. Exp Hematol 1989;17:1077-1080.
    • (1989) Exp Hematol , vol.17 , pp. 1077-1080
    • Monpezat, J.P.1    Frindel, E.2
  • 37
    • 0031766812 scopus 로고    scopus 로고
    • In vivo effect of Goralatide after 5-fluorouracil administration on murine hematopoiesis and AcSDKP metabolism
    • Comte L, Lorgeot V, Bignon J et al. In vivo effect of Goralatide after 5-fluorouracil administration on murine hematopoiesis and AcSDKP metabolism. Eur J Clin Invest 1998;20:856-863.
    • (1998) Eur J Clin Invest , vol.20 , pp. 856-863
    • Comte, L.1    Lorgeot, V.2    Bignon, J.3
  • 38
    • 0004145024 scopus 로고
    • A new physiological role of ACE in the regulation of hematopoiesis?
    • Wdzieczak-Bakala J, Rousseau A, Robinson S et al. A new physiological role of ACE in the regulation of hematopoiesis? STEM CELLS 1995;13:566.
    • (1995) STEM CELLS , vol.13 , pp. 566
    • Wdzieczak-Bakala, J.1    Rousseau, A.2    Robinson, S.3
  • 39
    • 0028913481 scopus 로고
    • AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia
    • Liozon E, Volkov L, Comte L et al. AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia. Br J Haematol 1995;89:917-920.
    • (1995) Br J Haematol , vol.89 , pp. 917-920
    • Liozon, E.1    Volkov, L.2    Comte, L.3
  • 40
    • 0021833338 scopus 로고
    • Enkephalin pseudopeptides: Resistance to in vitro proleolytic degradation afforded by amide bond replacement extends to remote sites
    • Benovitz DE, Spatola AF. Enkephalin pseudopeptides: resistance to in vitro proleolytic degradation afforded by amide bond replacement extends to remote sites. Peptides 1985;6:257-261.
    • (1985) Peptides , vol.6 , pp. 257-261
    • Benovitz, D.E.1    Spatola, A.F.2
  • 41
    • 0027716794 scopus 로고
    • The molecular specificity of action of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation
    • Robinson S, Lenfant M, Wdzieczak-Bakala J et al. The molecular specificity of action of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation. STEM CELLS 1993;11:422-427.
    • (1993) STEM CELLS , vol.11 , pp. 422-427
    • Robinson, S.1    Lenfant, M.2    Wdzieczak-Bakala, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.